FOXC1 and breast cancer: Using an independent clinically annotated breast cancer gene expression dataset, we confirmed the significant upregulation of FOXC1 in TNBC compared to non-TNBC in METABRIC cohort (Fig. 3d), and higher expression of FOXC1 correlates with poor overall survival of breast cancer patients (Fig. 3e).